E
Palvella Therapeutics, Inc. PVLA
$23.98 -$0.45-1.84%
Recommendation
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 09/30/2023
Total Cash And Short-Term Investments -2.27% 97.78% --
Total Receivables -- -- --
Inventory -- -- --
Prepaid Expenses 43.65% -- --
Finance Division Loans and Leases Current -- -- --
Total Finance Division Other Current Assets -- -- --
Other Current Assets 234.60% -- --
Total Current Assets 6.37% -- --

Total Current Assets 6.37% -- --
Net Property, Plant & Equipment -- -- --
Long-term Investments -- -- --
Goodwill -- -- --
Total Other Intangibles -- -- --
Finance Div Loans & Leases LT -- -- --
Total Finance Div Other LT Assets -- -- --
Total Other Assets -- -- --
Total Assets 6.37% -- --

Total Accounts Payable 116.46% -- --
Total Accrued Expenses 55.37% -- --
Short-term Debt -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- --
Finance Division Debt Current -- -- --
Total Finance Division Other Current Liabilities 22.08% -- --
Total Other Current Liabilities 22.08% -- --
Total Current Liabilities 73.72% -- --

Total Current Liabilities 73.72% -- --
Long-Term Debt 21.37% -- --
Short-term Debt -- -- --
Capital Leases -- -- --
Finance Division Debt Non Current -- -- --
Total Finance Division Other Non Current Liabilities -- -- --
Total Other Liabilities 5.58% -- --
Total Liabilities 29.54% -- --

Common Stock & APIC 9.12% -- --
Retained Earnings -8.16% -- --
Treasury Stock & Other -- -- --
Total Common Equity -8.14% -8.52% --

Preferred Stock Redeemable -- -- --
Preferred Stock Non Redeemable -- -- --
Preferred Stock Convertible 0.00% -- --
Preferred Stock, Others -- -- --
Total Preferred Equity 0.00% 0.00% --

Total Common Equity -8.14% -8.52% --
Total Preferred Equity 0.00% 0.00% --
Total Minority Interest -- -- --
Total Equity -64.31% -163.53% --

Weiss Ratings